A complete application in a minute — tailored resume and cover letter, ready to send.
Bristol Myers Squibb, based in New Jersey, seeks a translational development writer to produce biomarker reports and regulatory documents and to support publications for regulatory submissions. The role collaborates with TD scientists globally to ensure timely delivery of manuscripts, abstracts, and briefing materials.
The incumbent will help craft translational sections for submissions, coordinate with cross-functional teams, and contribute to scientific communications across disease areas.
At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.
Translational Development (TD) is part of the Global Research and Early Development organization in BMS and leads mid- to late-stage clinical, pharmacological, and translational research and development activities for the BMS pipeline. The Translational Development team supports the late-stage portfolio for regulatory, development and life cycle management. Translational Development at BMS has a long-standing history of scientific rigor as evidenced by our peer-reviewed publications, delivery of drug approvals, strong academic collaborations and talent development. Our areas of focus include but are not limited to Hematology, Oncology, Immunology, Cardiovascular and Neuroscience. This group integrates scientific learnings from the lab and clinic as well as business insights of multiple functions and leads the development of translational strategies at the franchise level.
Reporting to the Program Management Lead, the incumbent will be part of the late development translational group based in NJ and will be responsible for writing scientific documents including biomarker reports, regulatory documents (eg, non-clinical summaries, translational portions of clinical/pharmacology summaries, briefing books, CSRs, investigator brochures) in conjunction with Translational scientists. This individual will also contribute to abstracts, posters, manuscript and other scientific communications arising from the group.